EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Profiling Breast Tumor Heterogeneity and Identifying Breast Cancer Subtypes Through Tumor‐Associated Immune Cell Signatures and Immuno Nano Sensors

Deeptha Ishwar, Srilakshmi Premachandran, Sunit Das, Krishnan Venkatakrishnan, Bo Tan iD

Small · 2024-12 · 20 (52)

DOI: 10.1002/smll.202406475 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 26.10.2024. Verfasst von Deeptha Ishwar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Dentistry, Department of Stomatology, University of Montreal, Montreal, Quebec, H3T 1J4, Canada. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, NSERC Idea to Innovation grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is a complex and heterogeneous disease with varying cellular, genetic, epigenetic, and molecular expressions. The detection of intratumor heterogeneity in breast cancer poses significant challenges due to its complex multifaceted characteristics, yet its identification is crucial for guiding effective treatment decisions and understanding the disease progression. Currently, there exists no method capable of capturing the full extent of breast tumor heterogeneity. In this study, the aim is to identify and characterize metabolic heterogeneity in breast tumors using immune cells and an ultrafast laser‐fabricated Immuno Nano Sensor. Combining spectral markers from both Natural Killer (NK) and T cells, a machine‐learning approach is implemented to distinguish cancer from healthy samples, identify primary versus metastatic tumors, and determine estrogen receptor (ER)/progesterone receptor (PR) status at the single‐cell level. The platform successfully distinguished heterogeneous breast cancer samples from healthy individuals, achieving 97.8% sensitivity and 92.2% specificity, and accurately identified primary tumors from metastatic tumors. Characteristic spectral signatures allow for discrimination between ER/PR‐positive and negative tumors with 97.5% sensitivity. This study demonstrates the potential of immune cell‐based metabolic profiling in providing a comprehensive assessment of breast tumor heterogeneity and paving the way for minimally invasive liquid biopsy approaches in breast cancer diagnosis and management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleReceptors, EstrogenBiosensing TechniquesKiller Cells, NaturalNanotechnologyReceptors, ProgesteroneT-Lymphocytes

Stichwörter der Autor:innen

SERSbreast tumor heterogeneityimmune cellsliquid biopsynanosensor

Substanzen

Receptors, EstrogenReceptors, Progesterone

Autor:innen und Institutionen

  • Faculty of Dentistry, Department of Stomatology, University of Montreal, Montreal, Quebec, H3T 1J4, Canada.
  • Institute for Biomedical Engineering, Science and Technology (I BEST), Partnership between Toronto Metropolitan University and St. Michael's Hospital, Toronto, Ontario, M5B 1W8, Canada.
  • Ultrashort Laser Nanomanufacturing Research Facility, Faculty of Engineering and Architectural Sciences, Toronto Metropolitan University, 350 Victoria Street, Toronto, ON, M5B 2K3, Canada.
  • Nano Characterization Laboratory, Faculty of Engineering and Architectural Sciences, Toronto Metropolitan University, 350 Victoria Street, Toronto, Ontario, M5B 2K3, Canada.
  • Nano-Bio Interface facility, Faculty of Engineering and Architectural Sciences, Toronto Metropolitan University, 350 Victoria Street, Toronto, ON, M5B 2K3, Canada.
  • Department of Surgery, Division of Neurosurgery, University of Toronto, 30 Bond Street, Toronto, M5B1W8, Canada.

ORCID-Profile: Bo Tan

Förderung

  • Natural Sciences and Engineering Research Council of Canada
  • NSERC Idea to Innovation grant

Zitieren

APA

Ishwar, D., Premachandran, S., Das, S., Venkatakrishnan, K., & Tan, B. (2024). Profiling Breast Tumor Heterogeneity and Identifying Breast Cancer Subtypes Through Tumor‐Associated Immune Cell Signatures and Immuno Nano Sensors. Small, 20(52). https://doi.org/10.1002/smll.202406475

Vancouver

Ishwar D, Premachandran S, Das S, Venkatakrishnan K, Tan B. Profiling Breast Tumor Heterogeneity and Identifying Breast Cancer Subtypes Through Tumor‐Associated Immune Cell Signatures and Immuno Nano Sensors. Small. 2024;20(52). doi:10.1002/smll.202406475

BibTeX
@article{Ishwar2024,
  author = {Ishwar, Deeptha and Premachandran, Srilakshmi and Das, Sunit and Venkatakrishnan, Krishnan and Tan, Bo},
  title = {Profiling Breast Tumor Heterogeneity and Identifying Breast Cancer Subtypes Through Tumor‐Associated Immune Cell Signatures and Immuno Nano Sensors},
  journal = {Small},
  year = {2024},
  volume = {20},
  number = {52},
  doi = {10.1002/smll.202406475}
}
Kostenlos starten →